Childhood cancer incidence trends in association with US folic acid fortification (1986-2008)

Pediatrics

Volumn 129, Issue 6, 2012, Pages 1125-1133

  Linabery, Amy M ^a   Johnson, Kimberly J ^b   Ross, Julie A ^a,c  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b WASHINGTON UNIVERSITY IN ST LOUIS   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Cancer; Child; Epidemiology; Folic acid; Incidence; Trends

Indexed keywords

FOLIC ACID;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; ASTROCYTOMA; CANCER INCIDENCE; CHILD; CHILDHOOD CANCER; CONFIDENCE INTERVAL; DIET SUPPLEMENTATION; EPENDYMOMA; HEPATOBLASTOMA; HUMAN; INFANT; MAJOR CLINICAL STUDY; MEDULLOBLASTOMA; NEPHROBLASTOMA; NEUROBLASTOMA; NEUROECTODERM TUMOR; PRESCHOOL CHILD; PRIORITY JOURNAL; REGRESSION ANALYSIS; RETINOBLASTOMA; RHABDOMYOSARCOMA; STATISTICAL MODEL; TROPHOBLASTIC TUMOR; UNITED STATES;

EID: 84861880945     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2011-3418     Document Type: Article

References (70)

1. Morrison K, Papapetrou C, Hol FA, et al. Susceptibility to spina bifida; an association study of five candidate genes. Ann Hum Genet. 1998;62(pt 5):379-396 (Pubitemid 29083996)
2. MRC Vitamin Study Research Group. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet. 1991;338(8760):131-137
3. Czeizel AE, Dobo M, Vargha P. Hungarian cohort-controlled trial of periconceptional multivitamin supplementation shows a reduction in certain congenital abnormalities. Birth Defects Res. 2004;70(11):853-861 (Pubitemid 39602196)
4. Centers for Disease Control. Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects. MMWR Recomm Rep. 1992;41(RR-14):1-7
5. Food and Drug Administration. Food standards: amendment of standards of identity for enriched grain products to require addition of folic acid. Fed Regist. 1996;61:8781- 8797
6. Yeung L, Yang Q, Berry RJ. Contributions of total daily intake of folic acid to serum folate concentrations. JAMA. 2008;300(21): 2486-2487
7. Centers for Disease Control. Folate status in women of childbearing age-United States, 1999. MMWR Morb Mortal Wkly Rep. 2000;49 (42):962-965
8. Williams LJ, Mai CT, Edmonds LD, et al. Prevalence of spina bifida and anencephaly during the transition to mandatory folic acid fortification in the United States. Teratology. 2002;66(1):33-39 (Pubitemid 34734388)
9. Grupp SG, Greenberg ML, Ray JG, et al. Pediatric cancer rates after universal folic acid flour fortification in Ontario. J Clin Pharmacol. 2011;51(1):60-65
10. French AE, Grant R, Weitzman S, et al. Folic acid food fortification is associated with a decline in neuroblastoma. Clin Pharmacol Ther. 2003;74(3):288-294 (Pubitemid 37083104)
11. Goh YI, Koren G. Prenatal supplementation with multivitamins and the incidence of pediatric cancers: clinical and methodological considerations. Pediatr Blood Cancer. 2008;50(suppl 2):487-489, discussion 498
12. Bunin GR, Meadows AT, Emanuel BS, Buckley JD, Woods WG, Hammond GD. Pre- and postconception factors associated with sporadic heritable and nonheritable retinoblastoma. Cancer Res. 1989;49(20):5730-5735 (Pubitemid 19256460)
13. Bunin GR, Kuijten RR, Buckley JD, Rorke LB, Meadows AT. Relation between maternal diet and subsequent primitive neuroectodermal brain tumors in young children. N Engl J Med. 1993;329(8):536-541 (Pubitemid 23232622)
14. Bunin GR, Kuijten RR, Boesel CP, Buckley JD, Meadows AT. Maternal diet and risk of astrocytic glioma in children: a report from the Childrens Cancer Group (United States and Canada). Cancer Causes Control. 1994; 5(2):177-187 (Pubitemid 24093386)
15. Sarasua S, Savitz DA. Cured and broiled meat consumption in relation to childhood cancer: Denver, Colorado (United States). Cancer Causes Control. 1994;5(2):141-148 (Pubitemid 24093382)
16. Michalek AM, Buck GM, Nasca PC, Freedman AN, Baptiste MS, Mahoney MC. Gravid health status, medication use, and risk of neuroblastoma. Am J Epidemiol. 1996;143(10): 996-1001 (Pubitemid 26140326)
17. Preston-Martin S, Pogoda JM, Mueller BA, Holly EA, Lijinsky W, Davis RL. Maternal consumption of cured meats and vitamins in relation to pediatric brain tumors. Cancer Epidemiol Biomarkers Prev. 1996;5(8): 599-605 (Pubitemid 26265153)
18. Preston-Martin S, Pogoda JM, Mueller BA, et al. Prenatal vitamin supplementation and risk of childhood brain tumors. Int J Cancer Suppl. 1998;11:17-22
19. Thompson JR, Gerald PF, Willoughby ML, Armstrong BK. Maternal folate supplementation in pregnancy and protection against acute lymphoblastic leukaemia in childhood: a case-control study. Lancet. 2001;358(9297): 1935-1940 (Pubitemid 34072874)
20. Wen W, Shu XO, Potter JD, et al. Parental medication use and risk of childhood acute lymphoblastic leukemia. Cancer. 2002;95(8): 1786-1794
21. Olshan AF, Smith JC, Bondy ML, Neglia JP, Pollock BH. Maternal vitamin use and reduced risk of neuroblastoma. Epidemiology. 2002;13(5):575-580
22. Bunin GR, Gallagher PR, Rorke-Adams LB, Robison LL, Cnaan A. Maternal supplement, micronutrient, and cured meat intake during pregnancy and risk of medulloblastoma during childhood: a Children's Oncology Group study. Cancer Epidemiol Biomarkers Prev. 2006;15(9):1660-1667 (Pubitemid 44497102)
23. Schüz J, Weihkopf T, Kaatsch P. Medication use during pregnancy and the risk of childhood cancer in the offspring. Eur J Pediatr. 2007;166(5):433-441 (Pubitemid 46450497)
24. Gale KB, Ford AM, Repp R, et al. Backtracking leukemia to birth: identification of clonotypic gene fusion sequences in neonatal blood spots. Proc Natl Acad Sci USA. 1997;94(25):13950-13954 (Pubitemid 28009690)
25. Taub JW, Ge Y. The prenatal origin of childhood acute lymphoblastic leukemia. Leuk Lymphoma. 2004;45(1):19-25 (Pubitemid 38181389)
26. Greaves MF, Maia AT, Wiemels JL, Ford AM. Leukemia in twins: lessons in natural history. Blood. 2003;102(7):2321-2333 (Pubitemid 37193565)
27. Woodward PJ, Sohaey R, Kennedy A, Koeller KK. From the archives of the AFIP: a comprehensive review of fetal tumors with pathologic correlation. Radiographics. 2005; 25(1):215-242 (Pubitemid 40186953)
28. Howlader N, Noone AM, Krapcho M, et al, eds. SEER cancer statistics review, 1975-2008. Bethesda, MD: National Cancer Institute, based on November 2010 SEER data submission; 2011. Available at: http://seer. cancer.gov/csr/1975- 2008. Accessed June 8, 2011
29. Pizzo PA, Poplack DG. Principles and Practice of Pediatric Oncology. 5th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2006
30. Surveillance, Epidemiology, and End Results Program (SEER). SEER*Stat database: incidence -SEER 9 Regs Research Data, November2010 Sub (1973-2008) [Single Ages to 85+, Katrina/Rita Population Adjustment]- linked to county attributes-total US, 1969- 2009 counties. National Cancer Institute, Division of Cancer Control and Population Sciences, Surveillance Research Program, Cancer Statistics Branch, released April 2011, based on the November 2010 submission. Available at www.seer.cancer.gov. Accessed January 12, 2012
31. Zippin C, Lum D, Hankey BF. Completeness of hospital cancer case reporting from the SEER Program of the National Cancer Institute. Cancer. 1995;76(11):2343-2350
32. Steliarova-Foucher E, Stiller C, Lacour B, Kaatsch P. International Classification of Childhood Cancer, third edition. Cancer. 2005;103(7):1457-1467 (Pubitemid 40410743)
33. SEER*Stat software version 7.0.4. Bethesda, MD: Surveillance Research Program, National Cancer Institute. 2011. Available at: www.seer. cancer.gov/seerstat. Accessed October 17, 2011
34. Joinpoint Regression Program. Version 3.5.0. Bethesda, MD: Statistical Research and Applications Branch, National Cancer Institute; April 2011. Available at: http:// surveillance.cancer.gov/joinpoint. Accessed May 27, 2011
35. Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med. 2000;19(3):335-351 (Pubitemid 30070608)
36. Cohen RA. An Introduction to PROC LOESS for local regression. Proceedings of the 24th SAS Users Group International Conference, Miami, FL, April 1999; Paper 273. Cary, NC: SAS Institute, Inc.; 1999.
37. Blount BC, Mack MM, Wehr CM, et al. Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: implications for cancer and neuronal damage. Proc Natl Acad Sci USA. 1997;94 (7):3290-3295
38. Kim YI. Folic acid supplementation and cancer risk: point. Cancer Epidemiol Biomarkers Prev. 2008;17(9):2220-2225
39. Centers for Disease Control and Prevention (CDC). Use of supplements containing folic acid among women of childbearing age- United States, 2007. MMWR Morb Mortal Wkly Rep. 2008;57(1):5-8
40. Caughey RW, Michels KB. Birth weight and childhood leukemia: a meta-analysis and review of the current evidence. Int J Cancer. 2009;124(11):2658-2670
41. Harder T, Plagemann A, Harder A. Birth weight and subsequent risk of childhood primary brain tumors: a meta-analysis. Am J Epidemiol. 2008;168(4):366-373
42. Schüz J, Schmidt LS, Kogner P, et al. Birth characteristics and Wilms tumors in children in the Nordic countries: a registerbased case-control study. Int J Cancer. 2011;128(9):2166-2173
43. Puumala SE, Soler JT, Johnson KJ, Spector LG. Birth characteristics and Wilms tumor in Minnesota. Int J Cancer. 2008;122(6): 1368-1373 (Pubitemid 351287238)
44. Ognjanovic S, Carozza SE, Chow EJ, et al. Birth characteristics and the risk of childhood rhabdomyosarcoma based on histological subtype. Br J Cancer. 2010;102(1): 227-231
45. Ly A, Lee H, Chen J, et al. Effect of maternal and postweaning folic acid supplementation on mammary tumor risk in the offspring. Cancer Res. 2011;71(3):988-997
46. Sie KK, Medline A, van Weel J, et al. Effect of maternal and postweaning folic acid supplementation on colorectal cancer risk in the offspring. Gut. 2011;60(12):1687-1694
47. Spector LG, Johnson KJ, Soler JT, Puumala SE. Perinatal risk factors for hepatoblastoma. Br J Cancer. 2008;98(9):1570-1573 (Pubitemid 351652330)
48. Birch JM, Marsden HB. A classification scheme for childhood cancer. Int J Cancer. 1987;40(5):620-624 (Pubitemid 18003849)
49. Kramárová E, Stiller CA. The international classification of childhood cancer. Int J Cancer. 1996;68(6):759-765 (Pubitemid 27062037)
50. Scheithauer BW. Development of the WHO classification of tumors of the central nervous system: a historical perspective. Brain Pathol. 2009;19(4):551-564
51. World Health Organization. International Classification of Diseases for Oncology. Geneva, Switzerland: World Health Organization; 1976
52. Percy C, Van Holten V, et al World Health Organization. International Classification of Diseases for Oncology. 2nd ed. Geneva, Switzerland: World Health Organization; 1990
53. Fritz AG; World Health Organization. International Classification of Diseases for Oncology: ICD-O. 3rd ed. Geneva, Switzerland: World Health Organization; 2000
54. Delemarre JF, Sandstedt B, Harms D, Boccon- Gibod L, Vujanić GM; International Society of Paediatric Oncology. The new SIOP (Stockholm) working classification of renal tumours of childhood. Med Pediatr Oncol. 1996;26(2): 145-146 (Pubitemid 26010943)
55. Wright AJ, Dainty JR, Finglas PM. Folic acid metabolism in human subjects revisited: potential implications for proposed mandatory folic acid fortification in the UK. Br J Nutr. 2007;98(4):667-675 (Pubitemid 47487933)
56. Preston-Martin S, Yu MC, Benton B, Henderson BE. N-Nitroso compounds and childhood brain tumors: a case-control study. Cancer Res. 1982;42(12):5240-5245 (Pubitemid 13223175)
57. Lubin F, Farbstein H, Chetrit A, et al. The role of nutritional habits during gestation and child life in pediatric brain tumor etiology. Int J Cancer. 2000;86(1):139-143 (Pubitemid 30134000)
58. Dockerty JD, Herbison P, Skegg DC, Elwood M. Vitamin and mineral supplements in pregnancy and the risk of childhood acute lymphoblastic leukaemia: a case-control study. BMC Public Health. 2007;7:136
59. Milne E, Royle JA, Miller M, et al. Maternal folate and other vitamin supplementation during pregnancy and risk of acute lymphoblastic leukemia in the offspring. Int J Cancer. 2010;126(11):2690-2699
60. Robison LL, Buckley JD, Daigle AE, et al. Maternal drug use and risk of childhood nonlymphoblastic leukemia among offspring. An epidemiologic investigation implicating marijuana (a report from the Childrens Cancer Study Group). Cancer. 1989;63(10): 1904-1911 (Pubitemid 19118887)
61. Pombo-de-Oliveira MS, Koifman S; Brazilian Collaborative Study Group of Infant Acute Leukemia. Infant acute leukemia and maternal exposures during pregnancy. Cancer Epidemiol Biomarkers Prev. 2006;15(12): 2336-2341
62. Buckley JD, Sather H, Ruccione K, et al. A case-control study of risk factors for hepatoblastoma. A report from the Childrens Cancer Study Group. Cancer. 1989;64(5): 1169-1176 (Pubitemid 19208876)
63. Shu XO, Nesbit ME, Buckley JD, Krailo MD, Robinson LL. An exploratory analysis of risk factors for childhood malignant germ-cell tumors: report from the Childrens Cancer Group (Canada, United States). Cancer Causes Control. 1995;6(3):187-198
64. Johnson KJ, Poynter JN, Ross JA, Robison LL, Shu XO. Pediatric germ cell tumors and maternal vitamin supplementation: a Children's Oncology Group study. Cancer Epidemiol Biomarkers Prev. 2009;18(10):2661-2664
65. Duthie SJ. Folic acid deficiency and cancer: mechanisms of DNA instability. Br Med Bull. 1999;55(3):578-592
66. Kim YI. Folate and carcinogenesis: evidence, mechanisms, and implications. J Nutr Biochem. 1999;10(2):66-88
67. Wilson AS, Power BE, Molloy PL. DNA hypomethylation and human diseases. Biochim Biophys Acta. 2007;1775(1):138-162 (Pubitemid 44881198)
68. Surveillance, Epidemiology, and End Results (SEER) Program. Number of persons by race and hispanic ethnicity for SEER participants (2000 US Census data). Available at: http://seer.cancer.gov/registries/data.html. Accessed January 10, 2012
69. Surveillance, Epidemiology, and End Results (SEER) Program. Population characteristics, characteristics of the SEER population compared with the total United States population (2000 US Census data). Available at: http://seer.cancer.gov/registries/characteristics. html. Accessed January 10, 2012
70. National Program of Cancer Registries. 1999-2008 Incidence, WONDER On-line Database. Washington, DC: US Department of Health and Human Services; Atlanta, GA: Centers for Disease Control and Prevention; Washington, DC: National Cancer Institute; 2011